Results for tag: "Chronic Total Occlusion"

The Chronic Total Occlusion (CTO) market is a subset of the cardiology market that focuses on the treatment of coronary artery blockages. CTOs are blockages that have been present for more than three months and are considered to be the most difficult to treat. Treatment of CTOs requires specialized techniques and equipment, such as guidewires, balloons, and stents. The CTO market is highly competitive, with a variety of companies offering products and services to cardiologists. Companies in the CTO market include Abbott, Boston Scientific, Medtronic, Terumo, and Asahi Intecc. These companies offer a range of products and services, including guidewires, balloons, stents, and other medical devices. Additionally, many of these companies provide educational resources and training programs to help cardiologists stay up to date on the latest CTO treatments. Show Less Read more